The Pharmacy Times® Oncology resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.
What can we help you find?
The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.
Although cancer deaths with the highest death rates per capita accounted for the greatest number of years lost, the study authors said cancers that typically occur in younger populations had a disproportionate share of the burden.
Pharmacists can play an integral role in educating patients with breast cancer to improve health outcomes.
Pharmacy-Integrated Telehealth Solutions Support Patients with Orphan and Ultraorphan Disorders During and After COVID-19 Pandemic
A recent poll showed that more than 1 in 8 Americans engaged in a video consult with a health care professional in recent months.
Strategies and types of tests used by clinicians to help exclude various conditions that may present similarly to immune thrombocytopenia during a diagnostic work-up.
Early diagnosis, surgery while cancer is confined to kidney are key, but pharmacological agents are used for Stage IV.
Although ICIs have demonstrated excellent efficacy, they also have been associated with unique irAEs.
This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.
Study: AI May Help Predict Response to Immune Checkpoint Blockade in Patients With Metastatic Melanoma
To analyze digital images of metastatic tumors of melanoma, the researchers used computer algorithms, or deep convolutional neural networks (DCCN), to identify patterns associated with treatment response.
Janssen Submits FDA Application for Subcutaneous Daratumumab for Relapsed, Refractory Multiple Myeloma
It can be administered as a fixed-dose formulation over approximately 3 to 5 minutes, which is significantly less time than the intravenous (IV) formulation.
A discussion on the risks of bleeding episodes and venous thromboembolism associated with immune thrombocytopenia.
By supplying proper PPE and infrastructure, health systems can keep workers safe and provide excellent patient care.